Ceribell, Inc. cotiza a 25.26 USD y tiene una capitalización bursátil de $969M. En los últimos 12 meses ha facturado $102M con un margen de flujo de caja libre del -46.7%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.40 | $-0.38 | $-0.36 |
| Estimado | $-0.54 | $-0.46 | $-0.39 | $-0.41 |
| Sorpresa | — | +13.0% | +2.6% | +12.2% |
| Métrica | CBLL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 87.9% | 57.0% | +30.9% |
| Operating Margin | -65.6% | -38.6% | -26.9% |
| Net Margin | -60.0% | -33.6% | -26.4% |
| FCF Margin | -46.7% | -13.9% | -32.8% |
| ROE | -34.4% | -40.4% | +6.0% |
| ROA | -27.3% | -32.0% | +4.7% |
| Current Ratio | 9.73 | 2.84 | +6.89 |
| Debt / Equity | 0.13 | 0.28 | -0.15 |